Miraca Life Sciences Names Ranjitha Veerappan, MD, as Director of Molecular Genetics
Veerappan is responsible for leading the company’s molecular pathology services and research for hematology/oncology.
Irving, Texas (PRWEB) May 15, 2014
Miraca Life Sciences, (MLS) the nation’s largest independent anatomic pathology lab, has named Ranjitha Veerappan, MD, as Director of Molecular Genetics, responsible for leading the company’s molecular pathology services and research for hematology/oncology.
Dr. Veerappan is board-certified in anatomic and clinical pathology, molecular genetic pathology and hematopathology, having completed her molecular genetic pathology fellowship at Virginia Commonwealth University, and hematopathology fellowship at Loyola University Medical Center. She also served as Chief Resident during her pathology residency at East Tennessee State University. Dr. Veerappan also served a one-year residency at Northwestern University in Chicago. She has co-authored a number of peer-reviewed articles on the topics of hematopathology and molecular pathology.
Dr. Veerappan previously served as a Hematopathologist and Director of Molecular Pathology at siParadigm Diagnostic Informatics in Oradell, N.J. Additionally, she had held a similar role at Hematogenix Laboratory Services in Tinley Park, Ill.
“The addition of Dr. Veerappan to our hematopathology team demonstrates Miraca’s continued focus on adding expertise in molecular genetics and hematopathology,” said Michael Miller, MD, Medical Director of Hematopathology at Miraca. “Dr. Veerappan’s role as Director of Molecular Genetics will be critical to advancing Miraca’s ongoing mission to provide the most advanced, clinically appropriate testing for all of our patients.”
About Miraca Life Sciences
Miraca Life Sciences specializes in the development and commercialization of the highest quality academic pathology services, primarily in the fields of dermatology, hematology, gastroenterology and urology. The company’s core team of more than 90 academic-caliber specialists utilizes state-of-the-art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 5,500 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/05/prweb11854913.htm